Founder: Colin Carpenter

Siris Medical improves oncology outcomes through AI-enabled decisioning based on analysis and comparison of over 10 million clinical images and over 30,000 expert treatments. InsightRT: the Siris Medical commercialized, FDA-cleared software suite, uses AI to match each new patient to a massive, proprietary, expert database in order to precisely tailor treatment to each patient’s unique characteristics.  InsightRT leads to faster, better clinical decision making with better clinical outcomes for patients and more cost-effective care delivery for payers.